Arkolith/Insider Trading/ROIV/Form 4

Venker Eric

President & Immunovant CEORoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Dec 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.2M
Net Open-Market Flow
-$6.2M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 24, 2025Sell(S)75K$22.53$1.7M1.7M
Dec 24, 2025Option exercise(M)118K$3.85$454K1.7M
Dec 23, 2025Sell(S)200K$22.45$4.5M1.6M
Dec 23, 2025Option exercise(M)314K$3.85$1.2M1.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 24, 2025Option exercise(M)118K—$05.4M
Dec 23, 2025Option exercise(M)314K—$05.6M

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-046786) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML